Skip to main content
. 2020 Oct 28;9(4):258–270. doi: 10.7762/cnr.2020.9.4.258

Table 1. Baseline participants demographics and clinical characteristics.

Clinical characteristics SPB-201 (n = 38) Placebo (n = 41) Total (n = 79) p value
Sex 0.3331
Male 26 (68.42) 32 (78.05) 58 (73.42)
Female 12 (31.58) 9 (21.95) 21 (26.58)
Age (yr) 0.6794*
Mean ± SD 48.00 ± 12.63 49.20 ± 12.94 48.62 ± 12.73
Min–Max 20.00–67.00 19.00–73.00 19.00–73.00
Weight (kg) 0.6881*
Mean ± SD 76.02 ± 16.15 77.45 ± 15.93 76.77 ± 16.05
Min–Max 48.1–117.4 53.2–144.5 48.1–144.5
BMI (kg/m2) 0.3499*
Mean ± SD 26.65 ± 3.87 27.53 ± 4.26 27.10 ± 4.10
Min–Max 18.24–34.79 22.48–47.73 18.24–47.73
Exercise 0.8229
No 14 (36.84) 18 (43.90) 32 (40.51)
1–2 times/week 9 (23.68) 12 (29.27) 21 (26.58)
3–4 times/week 10 (26.32) 8 (19.51) 18 (22.78)
5–6 times/week 3 (7.89) 2 (4.88) 5 (6.33)
Everyday 2 (5.26) 1 (2.44) 3 (3.80)
Smoking 0.2203
No 22 (57.89) 20 (48.78) 42 (53.16)
Ex-smoker (over a year) 3 (7.89) 9 (21.95) 12 (15.19)
Smoker 13 (34.21) 12 (29.27) 25 (31.65)
HFD 0.8381
No 4 (10.53) 6 (14.63) 10 (12.66)
1–2 times/week 27 (71.05) 27 (65.85) 54 (68.35)
3 or more/week 7 (18.42) 8 (19.51) 15 (18.99)

SD, standard deviation; BMI, body mass index; HFD, high fat diet.

*The p value by 2 sample t-test; p value by χ2 test; p value by Fisher's exact test.